VIG Partners Adds Ultra V and ATGC, Launches Livscience
LG Chem's former aesthetics business, a skin-booster company and a botulinum toxin developer are combined into one medical aesthetics company.
FI Bio & Healthcare #medical-aesthetics #bolt-on
Deal value
—
Stake
—
EV / Revenue
—
EV / EBITDA
—
Lead
Private equity firm VIG Partners added skin-booster company Ultra V and botulinum toxin developer ATGC as bolt-ons to LG Chem’s aesthetics business, which it acquired in 2025. The three companies were combined and launched as Livscience in June 2026. The price and stakes were not disclosed.
Why this matters
It is a sector-integration investment that brings fillers, skin boosters and toxins into one company. It shows a private equity firm building a medical aesthetics platform through bolt-ons.
Deal terms
| Item | Figure |
|---|---|
| Targets | Ultra V and ATGC (combined with LG Chem’s former aesthetics business) |
| Combined company | Livscience (launched June 2026) |
| Price and stakes | Not disclosed |